272BIO

Beeches Farm Road Maple Barn /

TN22 5QD Uckfield

GB

272BIO

Foundation date

19/07/2019

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

272BIO are developing biotherapeutics, using innovative technologies, for livestock and companion animal disorders. Applying novel technologies, we are able to reduce hitherto prohibitive production costs and produce affordable therapies.  VHH antibodies enable 272BIO to design bespoke drugs for optimal disease control.

Upcoming events

Latest news

  • Bone Therapeutics agrees final settlement with the FSMA regarding clinical studies communication issues in 2016 and 2017

    22 hours ago

  • eTheRNA immunotherapies appoints Mathieu Lane as Chief Financial Officer and President of eTheRNA Inc. located in the U.S.A

    1 day ago

  • Allegro inaugrates new lab at Bluechem

    1 day ago